Acute Abdomen in Kawasaki Disease

Learn more about:
Related Clinical Trial
Clinical Precise Diagnosis and Treatment in the Kawasaki Disease A Blood Test to Diagnose Kawasaki Disease Defibrotide in Children With High Risk Kawasaki Disease Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease A Randomized Phase III Multicenter Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study) Prevention of Coronary Aneurysms in Kawasaki Syndrome A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease Anakinra and Kawasaki Disease Study of Combined Therapy of Aspirin and “IVIG-SN” in Kawasaki Disease Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease Cardiovascular Status of Children 5 Years After Kawasaki Disease Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young Adults With KD. A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki Disease Etanercept in Kawasaki Disease Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease Infliximab (Remicade) for Patients With Acute Kawasaki Disease Acute Abdomen in Kawasaki Disease Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017 Different Doses of IVIG for Kawasaki Disease Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 Measurement of Antibodies in Adults With a History of Kawasaki Disease Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease Genetic Determinants of Kawasaki Disease Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised Trial KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease

Brief Title

Acute Abdomen in Kawasaki Disease

Official Title

Acute Abdomen in Kawasaki Disease: Case Reports

Brief Summary

      Clinical and histopathological description of three cases of Kawasaki disease with acute
      abdomen.
    

Detailed Description

      CASE PRESENTATION Case 1 An 8 year-old male started 48 hrs prior to admission with abdominal
      pain in the right lower quadrant associated with vomiting and fever. The physical examination
      revealed discrete bilateral conjunctival hiperemia, right cervical adenomegaly, and severe
      abdominal pain in the right lower quadrant with a positive McBurney sign. Laboratory tests
      showed CBC: Hb 14.1 g/dl, WBC 13,800, NT 81%, LT 3%, Plt 383,000/μl. C-reactive protein 230.9
      mg/dl, BNP 106.4 pg/ml (0-99). Abdominal ultrasound confirmed the diagnosis of appendicitis.
      A laparoscopic appendectomy was performed, and appendiceal distal enlargement with
      fibrinopurulent tissue was found. Twelve hours after surgery, the patient presented increased
      conjunctival hyperaemia, generalized rash as well as upper extremities edema and
      desquamation, meeting criteria for Kawasaki disease. Cardiological evaluation showed mild
      pericardial effusion (3mm), normal coronary arteries. Intravenous immunoglobulins (IVIG),
      aspirin and steroids were started with resolution of the fever, rash and the conjunctival
      erythema.

      Case 2. A 6-year-old male started 15 days prior to admission with fever. He presented hands
      and feet edema and a generalized exantema. He was diagnosed with scarlet fever. The patient
      presented conjunctival hyperemia and cheilitis. On day 15 the patient had severe abdominal
      pain (right lower quadrant), and was hospitalized with the diagnosis of appendicitis. An
      appendicetomy was performed and two perforations of the appendix were found. Appendicitis was
      found (Figure 1). The patient persisted with fever and desquamation of perineal area, fingers
      and toes were added to the clinical picture. Laboratories reported blood count: Hb 13 g/dl,
      WBC 47,700/mm3 neutrophils 95% bands 8% platelets 551,000/μl, C-reactive protein 19.7 mg/dl,
      ESR 53 mm/hr, hypoalbuminemia 2.2 g/dl. Diagnosis of KD was established and IVIG 2 g/kg and
      aspirin were administered. Echocardiogram was normal. Surgical wound culture was reported
      positive for Enterococcus faecium and Escherchia coli. Antibiotic therapy was administered
      for 14 days with good evolution.

      Case 3. A 5-year-old male patient, presented with a history of fever for 5 days diagnosed as
      bacterial tonsillitis and treated with antibiotics without resolution. On the fifth day the
      patient developed bilateral conjunctivitis, erythema on the lips, morbilliform exanthema in
      the anterior and posterior thorax and abdominal pain in mesogastrium and right lower
      cuadrant. His physical examination revealed non-purulent bilateral conjunctivitis, cracked
      lips, strawberry tongue, cervical lymphadenopathy of 0.5 x 1 cm, exanthema in thoracic and
      dorsal region, with significant erythema of palms and soles, without skin exfoliation. The
      patient presented with severe abdominal pain located in the right lower quadrant, with signs
      of peritoneal irritation. Abdominal ultrasound was performed and was suggestive of acute
      appendicitis. Laboratories reported blood count: Hb 14.1 g/dl, Hcto 40.5%, WBC 3400 /uL,
      neutrophils 3100/uL, lymphocytes 300 103/uL, platelets 41,000 103/uL; ferritin 1700 ng/ml,
      triglycerids 190 mg/dl, C-reactive protein 8 mg/dl, normal hepatic and renal function. A
      diagnosis of KD and acute appendicitis was made. Treatment was started with IVIG and aspirin.
      The boy was taken to diagnostic laparoscopy where periappendicular inflammation was found.
      The cecal appendix biopsy presented normal morphology up to the serous layer, with congestive
      vessels, interstitial edema, and mild inflammatory infiltrate with predominantly mononuclear
      cells within the lymphatic vessels (Figure 2). A final diagnosis of mild mononuclear
      periappendicitis was made. The patient had an uneventful evolution with resolution of the
      symptoms.
    


Study Type

Observational


Primary Outcome

Kawasaki disease presenting with acute abdomen


Condition

Kawasaki Disease

Intervention

appendicectomy


Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Procedure

Estimated Enrollment

3

Start Date

April 14, 2016

Completion Date

February 15, 2019

Primary Completion Date

February 15, 2019

Eligibility Criteria

        Inclusion Criteria:

          -  Patients with Kawasaki disease.

          -  Acute abdomen requiring surgery.

        Exclusion Criteria:

          -  Patients with chronic gastrointestinal disease.

          -  Incomplete data on the charts.
      

Gender

All

Ages

1 Month - 18 Years

Accepts Healthy Volunteers

No

Contacts

, , 



Administrative Informations


NCT ID

NCT03902262

Organization ID

01-04-2019


Responsible Party

Sponsor

Study Sponsor

National Institute of Pediatrics, Mexico


Study Sponsor

, , 


Verification Date

April 2019